Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes.

Area of Science:

• Genomics
• Oncology
• Biostatistics

Background:

• Current breast cancer prognosis and chemotherapy prediction models require enhancement.
• Gene expression profiling offers a promising avenue for refining these models.

Purpose of the Study:

• To develop a novel risk model integrating gene expression-based intrinsic subtypes for improved breast cancer prognosis.
• To enhance the prediction of chemotherapy benefit in breast cancer patients.

Main Methods:

• A 50-gene subtype predictor was developed using microarray and qRT-PCR data.
• Prognostic significance was evaluated in 761 patients, and chemotherapy response was assessed in 133 patients.

Main Results:

• Intrinsic subtypes demonstrated significant prognostic value, independent of standard clinical parameters.
• A combined prognostic model incorporating intrinsic subtype and clinical information significantly improved prediction accuracy.
• The intrinsic subtype model achieved a 97% negative predictive value for pathologic complete response to neoadjuvant chemotherapy.

Conclusions:

• Intrinsic subtype diagnosis provides significant prognostic and predictive information beyond standard parameters in breast cancer.
• A continuous risk score derived from intrinsic subtypes is valuable for managing node-negative breast cancers.
• The intrinsic subtypes and risk score aid in assessing the likelihood of neoadjuvant chemotherapy efficacy.